Spontaneous (Passive) Adverse Event Reporting

Spontaneous reporting is the voluntary, unsolicited submission of reports about suspected adverse drug reactions by health professionals, manufacturers, and patients to a national centre or regulator. It is the oldest and most widespread method of post-marketing safety surveillance and the principal way that new, rare, or unexpected drug hazards first come to attention.

Definition

Spontaneous (passive) adverse event reporting is a surveillance method in which suspected adverse drug reactions are voluntarily reported by observers, without any systematic effort to seek out cases, and collated for the purpose of detecting safety signals.

Scope

The entry covers what a spontaneous report is, who submits them, how they accumulate into national and international databases, and the design's defining strengths and limitations — above all under-reporting and the absence of a denominator. It is a methodological reference; it does not advise on managing individual reactions.

Core questions

• What information does a useful spontaneous report contain?
• Why is under-reporting an inherent feature of the method?
• Why can spontaneous data generate hypotheses but not measure incidence?
• How do spontaneous reports feed signal detection?

Key concepts

• Individual case safety report (ICSR)
• Voluntary reporting
• Under-reporting
• Absence of a denominator
• Reporting bias and stimulated reporting
• Hypothesis generation
• Disproportionality (e.g. proportional reporting ratio)

Mechanisms

A reporter who suspects that a medicine has caused harm submits a structured report — identifying the patient, the suspected drug, the reaction, and the temporal relationship — to a pharmacovigilance centre. Reports are coded with standard terminologies and pooled. Because the system records only reactions that someone notices, suspects, and bothers to report, the captured cases are a non-random and incomplete fraction of all events (under-reporting), and there is no count of how many people took the drug, so true incidence cannot be calculated. The value of the method lies in aggregation: when a particular drug-event pair is reported more often than expected relative to other reports, a disproportionality signal arises that warrants further investigation (Evans et al., 2001; Stricker & Psaty, 2004).

Clinical relevance

Spontaneous reporting underlies many of the safety warnings and label changes that clinicians rely on, and submitting reports is itself a professional contribution to drug safety. This entry explains how that evidence is generated; it describes a surveillance method and is not guidance for individual diagnosis or treatment.

Epidemiology

Spontaneous schemes are global and high-volume — national systems and the WHO international database together hold tens of millions of reports — yet quantitative studies consistently show that only a minority of serious reactions are ever reported, so the data describe relative reporting patterns rather than population frequencies (Härmark & van Grootheest, 2008; WHO, 2002).

History

Spontaneous reporting was institutionalised after the thalidomide disaster, with national schemes such as the United Kingdom's Yellow Card system established in 1964 and the WHO international monitoring programme begun in 1968. The approach later matured from simple case collation toward quantitative disproportionality methods that mine accumulated reports for signals (WHO, 2002; Evans et al., 2001).

Debates

How damaging is under-reporting to the method's usefulness?

Under-reporting is universal and variable, which biases comparisons and prevents incidence estimation; debate continues over how far the method can be trusted for anything beyond hypothesis generation and how reporting can be improved without introducing stimulated-reporting artefacts.

Key figures

• I. Ralph Edwards
• Jeffrey K. Aronson
• Stephen Evans
• Patrick Waller

Seminal works

• edwards-aronson-2000
• evans-2001

Frequently asked questions

Can a spontaneous reporting system tell you how common a side effect is?

No. Because there is no record of how many people took the drug (no denominator) and only a fraction of reactions are reported, spontaneous data can flag possible associations but cannot estimate true incidence.

Does a single spontaneous report prove a drug caused a reaction?

Not on its own. A spontaneous report records a suspicion; establishing causation requires causality assessment and, usually, corroboration from accumulated reports or other study designs.